Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
JACC. Cardiovascular Interventions|February 20, 2016
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II StudyIan T Meredith, Darren L Walters, Nicolas Dumonteil, et al.Lancet (London, England)|September 7, 2019
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trialDaniel J F M Thuijs, A Pieter Kappetein, Patrick W Serruys, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 17, 2017
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohortNicolas Dumonteil, Ian T Meredith, Daniel J Blackman, et al.International Journal of Cardiology|September 3, 2013
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) TrialVasim Farooq, Patrick W Serruys, Pascal Vranckx, et al.The New England Journal of Medicine|December 31, 2005
Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarctionAnthony H Gershlick, Amanda Stephens-Lloyd, Sarah Hughes, et al.JACC. Cardiovascular Interventions|July 20, 2013
Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) scoreVasim Farooq, Yvonne Vergouwe, Philippe Généreux, et al.Heart (British Cardiac Society)|November 11, 2015
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspectiveRuben L Osnabrugge, Elizabeth A Magnuson, Patrick W Serruys, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.Journal of the American College of Cardiology|August 2, 2014
Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trialYao-Jun Zhang, Javaid Iqbal, Carlos M Campos, et al.Pageof 14